相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics
Shannon L. Kordus et al.
NATURE REVIEWS MICROBIOLOGY (2022)
Towards Development of a Non-Toxigenic Clostridioides difficile Oral Spore Vaccine against Toxigenic C. difficile
Jaime Hughes et al.
PHARMACEUTICS (2022)
Vaccination for the Prevention of Infection among Immunocompromised Patients: A Concise Review of Recent Systematic Reviews
Kay Choong See
VACCINES (2022)
Genomic and Phenotypic Characterization of the Nontoxigenic Clostridioides difficile Strain CCUG37785 and Demonstration of Its Therapeutic Potential for the Prevention of C. difficile Infection
Shaohui Wang et al.
MICROBIOLOGY SPECTRUM (2022)
Development of an Effective Nontoxigenic Clostridioides difficile-Based Oral Vaccine against C. difficile Infection
Shaohui Wang et al.
MICROBIOLOGY SPECTRUM (2022)
Mucosal vaccines - fortifying the frontiers
Ed C. Lavelle et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial
Guy de Bruyn et al.
LANCET INFECTIOUS DISEASES (2021)
Clostridioides difficile phage biology and application
Joshua Heuler et al.
FEMS MICROBIOLOGY REVIEWS (2021)
Role of Polymeric Immunoglobulin Receptor in IgA and IgM Transcytosis
Hao Wei et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Colonisation Factor CD0873, an Attractive Oral Vaccine Candidate against Clostridioides difficile
Cansu Karyal et al.
MICROORGANISMS (2021)
Mimicking Native Display of CD0873 on Liposomes Augments Its Potency as an Oral Vaccine against Clostridioides difficile
Cansu Karyal et al.
VACCINES (2021)
Human gut-associated lymphoid tissues (GALT); diversity, structure, and function
Urs M. Morbe et al.
MUCOSAL IMMUNOLOGY (2021)
Dendritic cell migration in inflammation and immunity
Juan Liu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Vaccinations in patients with inflammatory bowel disease
Fabio Salvatore Macaluso et al.
DIGESTIVE AND LIVER DISEASE (2021)
Pathobionts: mechanisms of survival, expansion, and interaction with host with a focus on Clostridioides difficile
Harish Chandra et al.
GUT MICROBES (2021)
Clostridioides difficile phage biology and application
Joshua Heuler et al.
FEMS MICROBIOLOGY REVIEWS (2021)
A Phase 2 Study Evaluating the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Healthy US Adults Aged 65 to 85 Years
Nicholas Kitchin et al.
CLINICAL INFECTIOUS DISEASES (2020)
An overview on dosage forms and formulation strategies for vaccines and antibodies oral delivery
Faten Madani et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2020)
Vaccination in Patients with Inflammatory Bowel Diseases
Christine N. Manser et al.
DIGESTION (2020)
Regulatory T-cell therapy in Crohn's disease: challenges and advances
Jennie N. Clough et al.
GUT (2020)
Mucosal vaccines: Strategies and challenges
Miao Li et al.
IMMUNOLOGY LETTERS (2020)
Induction of a Specific Humoral Immune Response by Nasal Delivery of Bcla2ctd of Clostridioides difficile
Ana Raquel Maia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Effectiveness and cost-effectiveness of a Clostridium difficile vaccine candidate in a hospital setting
David Champredon et al.
VACCINE (2020)
In Vitro Production and Immunogenicity of a Clostridium difficile Spore-Specific BclA3 Glycopeptide Conjugate Vaccine
Annie Aubry et al.
VACCINES (2020)
IL-17-producing γδ T cells protect against Clostridium difficile infection
Yee-Shiuan Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Human C. difficile toxin-specific memory B cell repertoires encode poorly neutralizing antibodies
Hemangi B. Shah et al.
JCI INSIGHT (2020)
Novel therapies and preventative strategies for primary and recurrent Clostridium difficile infections
Michael G. Dieterle et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2019)
Clostridium difficile in Immunocompromised Hosts: A Review of Epidemiology, Risk Factors, Treatment, and Prevention
Sara Lynn Revolinski et al.
CLINICAL INFECTIOUS DISEASES (2019)
Status of vaccine research and development for Clostridium difficile
T. V. Riley et al.
VACCINE (2019)
Current and future trends in clostridioides (clostridium) difficile infection management
Sahil Khanna et al.
ANAEROBE (2019)
Vaccination against Clostridium difficile by Use of an Attenuated Salmonella enterica Serovar Typhimurium Vector (YS1646) Protects Mice from Lethal Challenge
Kaitlin Winter et al.
INFECTION AND IMMUNITY (2019)
Activated Peyer's patch B cells sample antigen directly from M cells in the subepithelial dome
Rathan Joy Komban et al.
NATURE COMMUNICATIONS (2019)
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults
Christopher Andrew Lamb et al.
GUT (2019)
Molecular features of lipoprotein CD0873: A potential vaccine against the human pathogen Clostridioides difficile
William J. Bradshaw et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Plasma Cells, the Next Generation: Beyond Antibody Secretion
Peter D. Pioli
FRONTIERS IN IMMUNOLOGY (2019)
Modelling diverse sources of Clostridium difficile in the community: importance of animals, infants and asymptomatic carriers
A. McLure et al.
EPIDEMIOLOGY AND INFECTION (2019)
The structure of the S-layer of Clostridium difficile
William J. Bradshaw et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2018)
Probiotics for prevention of Clostridium difficile infection
John P. Mills et al.
CURRENT OPINION IN GASTROENTEROLOGY (2018)
Development of vaccine for Clostridium difficile infection using membrane fraction of nontoxigenic Clostridium difficile
Mitsutoshi Senoh et al.
MICROBIAL PATHOGENESIS (2018)
Identification of Clostridium difficile Immunoreactive Spore Proteins of the Epidemic Strain R20291
Marjorie Pizarro-Guajardo et al.
PROTEOMICS CLINICAL APPLICATIONS (2018)
Clinical review of Clostridium difficile infection: an update on treatment and prevention
Lindsay M. Daniels et al.
EXPERT OPINION ON PHARMACOTHERAPY (2018)
Oral Immunization with Nontoxigenic Clostridium difficile Strains Expressing Chimeric Fragments of TcdA and TcdB Elicits Protective Immunity against C. difficile Infection in Both Mice and Hamsters
Yuanguo Wang et al.
INFECTION AND IMMUNITY (2018)
Clostridium difficile exosporium cysteine-rich proteins are essential for the morphogenesis of the exosporium layer, spore resistance, and affect C. difficile pathogenesis
Paulina Calderon-Romero et al.
PLOS PATHOGENS (2018)
Non-toxigenic Clostridioides (Formerly Clostridium) difficile for Prevention of C. difficile Infection: From Bench to Bedside Back to Bench and Back to Bedside
Dale N. Gerding et al.
FRONTIERS IN MICROBIOLOGY (2018)
Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection
Bhagyashri D. Navalkele et al.
BIOLOGICS-TARGETS & THERAPY (2018)
Bezlotoxumab Alone and With Actoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients on Standard of Care Antibiotics: Integrated Results of 2 Phase 3 Studies (MODIFY I and MODIFY II)
Mark Wilcox et al.
Open Forum Infectious Diseases (2017)
Characteristics of the Clostridium difficile cell envelope and its importance in therapeutics
Joseph A. Kirk et al.
MICROBIAL BIOTECHNOLOGY (2017)
Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing
Zhong Peng et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2017)
Barrier-tissue macrophages: functional adaptation to environmental challenges
Allan Mcl Mowat et al.
NATURE MEDICINE (2017)
Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains
Susan Secore et al.
PLOS ONE (2017)
Clostridium difficile in beef cattle farms, farmers and their environment: Assessing the spread of the bacterium
Cristina Rodriguez et al.
VETERINARY MICROBIOLOGY (2017)
Immunization with Recombinant TcdB-Encapsulated Nanocomplex Induces Protection against Clostridium difficile Challenge in a Mouse Model
Yi-Wen Liu et al.
FRONTIERS IN MICROBIOLOGY (2017)
The role of toxins in Clostridium difficile infection
Ramyavardhanee Chandrasekaran et al.
FEMS MICROBIOLOGY REVIEWS (2017)
Cytokines Are Markers of the Clostridium difficile-Induced Inflammatory Response and Predict Disease Severity
Hua Yu et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Mucosal Antibodies to the C Terminus of Toxin A Prevent Colonization of Clostridium difficile
Huynh A. Hong et al.
INFECTION AND IMMUNITY (2017)
Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies
Kasper Krogh Andersen et al.
INFECTION AND IMMUNITY (2016)
Fecal microbiota transplantation for the treatment of Clostridium difficile infection
Krishna Rao et al.
JOURNAL OF HOSPITAL MEDICINE (2016)
Immunogenicity and protective efficacy of Clostridium difficile spore proteins
Chandrabali Ghose et al.
ANAEROBE (2016)
Immunogenic properties of the surface layer precursor of Clostridium difficile and vaccination assays in animal models
J. -F. Bruxelle et al.
ANAEROBE (2016)
Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O'Toole 1935) Prevot 1938
Paul A. Lawson et al.
ANAEROBE (2016)
A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum hydroxide in healthy adults
Eric Sheldon et al.
VACCINE (2016)
Safety, immunogenicity and dose response of VLA84, a new vaccine candidate against Clostridium difficile, in healthy volunteers
Nicole Bezay et al.
VACCINE (2016)
Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial
Guy de Bruyn et al.
VACCINE (2016)
Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliC
Chandrabali Ghose et al.
EMERGING MICROBES & INFECTIONS (2016)
Vaccination in Primary Immunodeficiency Disorders
Ali Sobh et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2016)
Clostridium difficile infection
Wiep Klaas Smits et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
New advances in the treatment of Clostridium difficile infection (CDI)
Debra Farver
Therapeutics and Clinical Risk Management (2016)
Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes
J. Freeman et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Administration of Spores of Nontoxigenic Clostridium difficile Strain M3 for Prevention of Recurrent C difficile Infection A Randomized Clinical Trial
Dale N. Gerding et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Protein composition of the outermost exosporium-like layer of Clostridium difficile 630 spores
Fernando Diaz-Gonzalez et al.
JOURNAL OF PROTEOMICS (2015)
Inhibition of adhesion of Clostridium difficile to human intestinal cells after treatment with serum and intestinal fluid isolated from mice immunized with nontoxigenic C-difficile membrane fraction
Mitsutoshi Senoh et al.
MICROBIAL PATHOGENESIS (2015)
Clostridium difficile Infection
Daniel A. Leffler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The recombinant Lactococcus lactis oral vaccine induces protection against C. difficile spore challenge in a mouse model
Shanguang Guo et al.
VACCINE (2015)
Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections
Glen P. Carter et al.
MBIO (2015)
Humanized microbiota mice as a model of recurrent Clostridium difficile disease
James Collins et al.
MICROBIOME (2015)
Characterization of the collagen-like exosporium protein, BclA1, of Clostridium difficile spores
Marjorie Pizarro-Guajardo et al.
ANAEROBE (2014)
Small animal models for the study of Clostridium difficile disease pathogenesis
Melanie L. Hutton et al.
FEMS MICROBIOLOGY LETTERS (2014)
Lipoprotein CD0873 Is a Novel Adhesin of Clostridium difficile
Andrea Kovacs-Simon et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Functional analysis of SleC from Clostridium difficile: an essential lytic transglycosylase involved in spore germination
Danielle Gutelius et al.
MICROBIOLOGY-SGM (2014)
Intestinal macrophages and dendritic cells: what's the difference?
Vuk Cerovic et al.
TRENDS IN IMMUNOLOGY (2014)
Clostridium difficile spore biology: sporulation, germination, and spore structural proteins
Daniel Paredes-Sabja et al.
TRENDS IN MICROBIOLOGY (2014)
Intestinal antigen-presenting cells in mucosal immune homeostasis: Crosstalk between dendritic cells, macrophages and B-cells
Elizabeth R. Mann et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Vaccines against Clostridium difficile
Rosanna Leuzzi et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Clostridium difficile binary toxin CDT Mechanism, epidemiology, and potential clinical importance
Dale N. Gerding et al.
GUT MICROBES (2014)
Carbohydrate-based Clostridium difficile vaccines
Mario A. Monteiro et al.
EXPERT REVIEW OF VACCINES (2013)
Functional Characterization of Clostridium difficile Spore Coat Proteins
Patima Permpoonpattana et al.
JOURNAL OF BACTERIOLOGY (2013)
Expression and display of Clostridium difficile protein FliD on the surface of Bacillus subtilis spores
Alessandro Negri et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2013)
A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile
Robert G. K. Donald et al.
MICROBIOLOGY-SGM (2013)
Clostridium difficile Modulates Host Innate Immunity via Toxin-Independent and Dependent Mechanism(s)
Nazila V. Jafari et al.
PLOS ONE (2013)
Immunization Using GroEL Decreases Clostridium difficile Intestinal Colonization
Severine Pechine et al.
PLOS ONE (2013)
Horizontal gene transfer converts non-toxigenic Clostridium difficile strains into toxin producers
Michael S. M. Brouwer et al.
NATURE COMMUNICATIONS (2013)
Immunization in the adult immunocompromised host
Micha Loebermann et al.
AUTOIMMUNITY REVIEWS (2012)
Vaccination of immunocompromised patients
Per Ljungman
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Vaccination With Parenteral Toxoid B Protects Hamsters Against Lethal Challenge With Toxin A-Negative, Toxin B-Positive Clostridium difficile but Does Not Prevent Colonization
Farida Siddiqui et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
A novel fusion protein containing the receptor binding domains of C. difficile toxin A and toxin B elicits protective immunity against lethal toxin and spore challenge in preclinical efficacy models
Jing-Hui Tian et al.
VACCINE (2012)
Phase I dose finding studies of an adjuvanted Clostridium difficile toxoid vaccine
Richard N. Greenberg et al.
VACCINE (2012)
Isolated lymphoid follicles are dynamic reservoirs for the induction of intestinal IgA
Kathryn A. Knoop et al.
FRONTIERS IN IMMUNOLOGY (2012)
Models for the study of Clostridium difficile infection
Emma L. Best et al.
GUT MICROBES (2012)
Intravenous Immunoglobulin for the Treatment of Clostridium difficile Infection: A Review
Marwan S. Abougergi et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Encapsulation of Cwp84 into pectin beads for oral vaccination against Clostridium difficile
Chiara Sandolo et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2011)
Immunization of hamsters against Clostridium difficile infection using the Cwp84 protease as an antigen
Severine Pechine et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2011)
Colitis and Intestinal Inflammation in IL10(-/-) Mice Results From IL-13R alpha 2-Mediated Attenuation of IL-13 Activity
Mark S. Wilson et al.
GASTROENTEROLOGY (2011)
Immunology of gut mucosal vaccines
Marcela F. Pasetti et al.
IMMUNOLOGICAL REVIEWS (2011)
Immunization with Bacillus Spores Expressing Toxin A Peptide Repeats Protects against Infection with Clostridium difficile Strains Producing Toxins A and B
Patima Permpoonpattana et al.
INFECTION AND IMMUNITY (2011)
Mouse Relapse Model of Clostridium difficile Infection
Xingmin Sun et al.
INFECTION AND IMMUNITY (2011)
Comparison of the Burdens of Hospital-Onset, Healthcare Facility-Associated Clostridium difficile Infection and of Healthcare-Associated Infection due to Methicillin-Resistant Staphylococcus aureus in Community Hospitals
Becky A. Miller et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2011)
A proposed nomenclature for cell wall proteins of Clostridium difficile
Robert P. Fagan et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2011)
Chemical Probes of Surface Layer Biogenesis in Clostridium difficile
T. H. Tam Dang et al.
ACS CHEMICAL BIOLOGY (2010)
SleC Is Essential for Germination of Clostridium difficile Spores in Nutrient-Rich Medium Supplemented with the Bile Salt Taurocholate
David A. Burns et al.
JOURNAL OF BACTERIOLOGY (2010)
Antibiotic Treatment of Clostridium difficile Carrier Mice Triggers a Supershedder State, Spore-Mediated Transmission, and Severe Disease in Immunocompromised Hosts
Trevor D. Lawley et al.
INFECTION AND IMMUNITY (2009)
Clostridium difficile in Retail Meat Products, USA, 2007
J. Glenn Songer et al.
EMERGING INFECTIOUS DISEASES (2009)
Antimicrobial-associated risk factors for Clostridium difficile infection
Robert C. Owens et al.
CLINICAL INFECTIOUS DISEASES (2008)
Active immunization of hamsters against Clostridium difficile infection using surface-layer protein
Deirdre B. Ni Eidhin et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2008)
A Mouse Model of Clostridium difficile-Associated Disease
Xinhua Chen et al.
GASTROENTEROLOGY (2008)
Immunoreactive cell wall proteins of Clostridium difficile identified by human sera
Anne Wright et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2008)
A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: Efficacy and safety data of a prematurely interrupted trial
Eero Mattila et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2008)
Diminished intestinal colonization by Clostridium difficile and immune response in mice after mucosal immunization with surface proteins of Clostridium difficile
Severine Pechine et al.
VACCINE (2007)
Roundtrip ticket for secretory IgA: Role in mucosal homeostasis?
Blaise Corthesy
JOURNAL OF IMMUNOLOGY (2007)
Mucosal vaccines: the promise and the challenge
MR Neutra et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Clostridial enteric infections in pigs
JG Songer et al.
JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION (2005)
Variability of Clostridium difficile surface proteins and specific serum antibody response in patients with Clostridium difficile-associated disease
S Péchiné et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Passive immunisation of hamsters against Clostridium difficile infection using antibodies to surface layer proteins
JB O'Brien et al.
FEMS MICROBIOLOGY LETTERS (2005)
Clostridium difficile toxins:: Mechanism of action and role in disease
DE Voth et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Clostridium difficile toxoid vaccine in recurrent C-difficile-associated diarrhea
S Sougioultzis et al.
GASTROENTEROLOGY (2005)
Bovine antibody-enriched whey to aid in the prevention of a relapse of Clostridium difficile associated diarrhoea:: preclinical and preliminary clinical data
JT van Dissel et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2005)
Immunological properties of surface proteins of Clostridium difficile
S Péchiné et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2005)
Mucosal immune responses
DWK Acheson et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2004)
Passive antibody therapy for infectious diseases
A Casadevall et al.
NATURE REVIEWS MICROBIOLOGY (2004)
Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A
S Aboudola et al.
INFECTION AND IMMUNITY (2003)
Intestinal IgA synthesis: Regulation of front-line body defences
S Fagarasan et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Role of FliC and FliD flagellar proteins of Clostridium difficile in adherence and gut colonization
A Tasteyre et al.
INFECTION AND IMMUNITY (2001)
Characterization of a cell surface protein of Clostridium difficile with adhesive properties
AJ Waligora et al.
INFECTION AND IMMUNITY (2001)
Safety and immunogenicity of increasing doses of a Clostridium difficile toroid vaccine administered to healthy adults
KL Kotloff et al.
INFECTION AND IMMUNITY (2001)
GroEL (Hsp60) of Clostridium difficile is involved in cell adherence
C Hennequin et al.
MICROBIOLOGY-UK (2001)
Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.
L Kyne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
